85 related articles for article (PubMed ID: 11135508)
1. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored.
Magura S; Rosenblum A
Mt Sinai J Med; 2001 Jan; 68(1):62-74. PubMed ID: 11135508
[TBL] [Abstract][Full Text] [Related]
2. Redefining retention: recovery from the patient's perspective.
Mitchell SG; Morioka R; Reisinger HS; Peterson JA; Kelly SM; Agar MH; Brown BS; O'Grady KE; Schwartz RP
J Psychoactive Drugs; 2011; 43(2):99-107. PubMed ID: 21858956
[TBL] [Abstract][Full Text] [Related]
3. Reflections: Lessons Learned and Lessons Forgotten.
Doarn CR
Telemed J E Health; 2023 Dec; 29(12):1745-1746. PubMed ID: 38079621
[No Abstract] [Full Text] [Related]
4. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.
McCance-Katz EF; Sullivan LE; Nallani S
Am J Addict; 2010; 19(1):4-16. PubMed ID: 20132117
[TBL] [Abstract][Full Text] [Related]
5. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
Bentzley BS; Barth KS; Back SE; Book SW
J Subst Abuse Treat; 2015 May; 52():48-57. PubMed ID: 25601365
[TBL] [Abstract][Full Text] [Related]
7. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.
Bentzley BS; Barth KS; Back SE; Aronson G; Book SW
J Subst Abuse Treat; 2015 Sep; 56():48-53. PubMed ID: 25899872
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Mattick RP; Breen C; Kimber J; Davoli M
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
[TBL] [Abstract][Full Text] [Related]
9. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Minozzi S; Ferroni E; Ali R; Ferri M
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003409. PubMed ID: 23450540
[TBL] [Abstract][Full Text] [Related]
10. Lapse and relapse following inpatient treatment of opiate dependence.
Smyth BP; Barry J; Keenan E; Ducray K
Ir Med J; 2010 Jun; 103(6):176-9. PubMed ID: 20669601
[TBL] [Abstract][Full Text] [Related]
11. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Mattick RP; Breen C; Kimber J; Davoli M
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD002209. PubMed ID: 19588333
[TBL] [Abstract][Full Text] [Related]
12. The Psychiatrist's Role in Treating Perinatal Opioid Use Disorder and Reducing Maternal Mortality.
Witcraft SM; Johnson C; Guille C
Focus (Am Psychiatr Publ); 2024 Jan; 22(1):25-34. PubMed ID: 38694152
[TBL] [Abstract][Full Text] [Related]
13. Opioids in COVID-19: Two Sides of a Coin.
Palamim CVC; Boschiero MN; Faria AG; Valencise FE; Marson FAL
Front Pharmacol; 2021; 12():758637. PubMed ID: 35069193
[No Abstract] [Full Text] [Related]
14. Specificity of Varenicline in Blocking Mesolimbic Circuit Activation to Natural and Drug Rewards.
Goldstein N; Carty JRE; Betley JN
Neuroscience; 2022 Feb; 483():40-51. PubMed ID: 34923039
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.
Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z
JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402
[TBL] [Abstract][Full Text] [Related]
16. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.
Krawczyk N; Williams AR; Saloner B; Cerdá M
J Subst Abuse Treat; 2021 Jul; 126():108329. PubMed ID: 34116820
[TBL] [Abstract][Full Text] [Related]
17. Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment.
Arnold TD; Lin LA; Cotton BP; Bryson WC; Polenick CA
Subst Use Misuse; 2021; 56(4):529-538. PubMed ID: 33645425
[TBL] [Abstract][Full Text] [Related]
18. Are patients' goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder.
Rosic T; Naji L; Panesar B; Chai DB; Sanger N; Dennis BB; Marsh DC; Rieb L; Worster A; Thabane L; Samaan Z
BMJ Open; 2021 Jan; 11(1):e044017. PubMed ID: 33436476
[TBL] [Abstract][Full Text] [Related]
19. "That's No Longer Tolerated": Policing Patients' Use of Non-opioid Substances in Methadone Maintenance Treatment.
Frank D
J Psychoactive Drugs; 2021; 53(1):10-17. PubMed ID: 32996399
[TBL] [Abstract][Full Text] [Related]
20. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
